Literature DB >> 6404406

Role of carcinoembryonic antigen in detection of asymptomatic disseminated disease in colorectal carcinoma.

I G Finlay, C S McArdle.   

Abstract

Fifty one patients were studied prospectively to evaluate the role of sequential determinations of the carcino-embryonic antigen concentration in the detection of asymptomatic disseminated disease after curative resection for colorectal carcinoma. Computed tomography of the liver was performed during the immediate postoperative period in all patients. Serum concentrations of the antigen were estimated at three month intervals for a minimum of two years. Computed tomography at the time of operation detected occult hepatic metastases in 12 patients. Of the remaining 39 patients, six developed local recurrence alone, two developed disseminated disease in the absence of hepatic metastases, and one developed hepatic disease at 10 months, as detected by sequential computed tomography. Of all 13 patients with asymptomatic hepatic metastases, only eight developed an increase in serum carcinoembryonic antigen concentrations before death. The median interval between detection by computed tomography and rise in antigen concentrations was 7.5 months. The corresponding median interval from increase in concentration to death was only 5.5 months. Of the six patients who developed local recurrence alone, only two had raised concentrations of the antigen. These results suggest that increase in the serum carcinoembryonic antigen concentration occurs late in colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404406      PMCID: PMC1547230          DOI: 10.1136/bmj.286.6373.1242

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas.

Authors:  A M Mackay; S Patel; S Carter; U Stevens; D J Laurence; E H Cooper; A M Neville
Journal:  Br Med J       Date:  1974-11-16

2.  Long-term follow-up of colorectal carcinoma patients by repeated CEA radioimmunoassay.

Authors:  J P Mach; H Vienny; P Jaeger; B Haldemann; R Egely; J Pettavel
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

3.  Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer.

Authors:  P H Sugarbaker; N Zamcheck; F D Moore
Journal:  Cancer       Date:  1976-12       Impact factor: 6.860

4.  Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma.

Authors:  M A Herrera; T M Chu; E D Holyoke
Journal:  Ann Surg       Date:  1976-01       Impact factor: 12.969

5.  Carcinoembryonic antigen test for recurrent colorectal carcinoma. Inadequacy for early detection.

Authors:  C G Moertel; A J Schutt; V L Go
Journal:  JAMA       Date:  1978-03-13       Impact factor: 56.272

6.  The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures.

Authors:  E W Martin; K K James; P E Hurtubise; P Catalano; J P Minton
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

7.  The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.

Authors:  C B Wood; J G Ratcliffe; R W Burt; A J Malcolm; L H Blumgart
Journal:  Br J Surg       Date:  1980-01       Impact factor: 6.939

8.  Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?

Authors:  H J Wanebo
Journal:  Surgery       Date:  1981-03       Impact factor: 3.982

9.  The identification of patients at high risk following curative resection for colorectal carcinoma.

Authors:  I G Finlay; C S McArdle
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

10.  Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma.

Authors:  D J Laurence; U Stevens; R Bettelheim; D Darcy; C Leese; C Turberville; P Alexander; E W Johns; A M Neville
Journal:  Br Med J       Date:  1972-09-09
View more
  12 in total

1.  Unreviewed reports.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-04

2.  Liver function tests in patients with computed tomography demonstrated hepatic metastases.

Authors:  M D Ottmar; R L Gonda; K J Leithauser; O H Gutierrez
Journal:  Gastrointest Radiol       Date:  1989

3.  Symposium: The management of recurrent colorectal cancer.

Authors:  F F Attiyeh; H Ellis; M Killingback; G D Oates; P F Schofield; H J Staab; G Steele; P H Sugarbaker
Journal:  Int J Colorectal Dis       Date:  1986-07       Impact factor: 2.571

4.  The role of CEA, TPA and CA 19-9 in the early detection of recurrent colorectal cancer.

Authors:  P Barillari; G Ramacciato; R de Angelis; P Gozzo; P Aurello; M Indinnimeo; S Valabrega; F D'Angelo; G Fegiz
Journal:  Int J Colorectal Dis       Date:  1989-12       Impact factor: 2.571

5.  Carcinoembryonic antigen and recurrent colorectal cancer.

Authors:  J Northover
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

6.  A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.

Authors:  J Boey; H C Cheung; C K Lai; J Wong
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

7.  Raised carcinoembryonic antigen level as an indicator of recurrent disease in follow up of patients with colorectal cancer.

Authors:  W F Miles; J D Greig; J Seth; C Sturgeon; S J Nixon
Journal:  Br J Gen Pract       Date:  1995-06       Impact factor: 5.386

8.  [Effect of serial CEA determination on diagnosis, therapy and prognosis of recurrent colorectal cancer].

Authors:  B Mentges
Journal:  Langenbecks Arch Chir       Date:  1988

9.  Development of an ELISA to detect early local relapse of colorectal cancer.

Authors:  L G Durrant; H Jones; N C Armitage; R W Baldwin
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

Review 10.  Blood CEA levels for detecting recurrent colorectal cancer.

Authors:  Brian D Nicholson; Bethany Shinkins; Indika Pathiraja; Nia W Roberts; Tim J James; Susan Mallett; Rafael Perera; John N Primrose; David Mant
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.